Key Record Dates
ClinicalTrials.gov Identifier: | NCT06105632 |
---|---|
Brief Title: | A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment |
First Submitted : | October 24, 2023 |
First Submitted that Met QC Criteria : | October 24, 2023 |
First Posted : | October 27, 2023 |
Last Update Submitted that Met QC Criteria : | April 2, 2024 |
Last Update Posted : | April 3, 2024 |